Placenta accreta and methotrexate therapy: three case reports.
Placenta accreta is a complication that is rising in incidence. The reported experience of methotrexate treatment in the conservative management of placenta accreta is scant. Three cases of placenta accreta managed with methotrexate are presented. Case 1: A woman had an antenatal diagnosis of placenta percreta. A successful manual placental removal occurred on post-cesarean day 16. Case 2: A woman had retention of a placenta accreta after a term vaginal delivery. Successful dilation and curettage were performed on postpartum day 37. Case 3: A woman had an antenatal diagnosis of placenta previa-percreta with bladder invasion. A simple hysterectomy was performed on post-cesarean day 46. Conservative management and methotrexate treatment resulted in uterine preservation in two of our three patients; however, this treatment did not prevent significant delayed hemorrhage. In view of the rapid resolution of vascular invasion of the bladder, methotrexate may have an important role in the management of placenta percreta with bladder invasion. The utility of methotrexate treatment with the conservative management of placenta accreta requires further evaluation.
Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
G M
GM
Mussalli
J
J
Shah
D J
DJ
Berck
A
A
Elimian
N
N
Tejani
F A
FA
Manning
D000328:Adult; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D010921:Placenta Accreta / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D016896:Treatment Outcome; D001743:Urinary Bladder / Q000098:blood supply; D014592:Uterine Hemorrhage / Q000209:etiology; D014652:Vascular Diseases / Q000188:drug therapy / Q000209:etiology
D008727:Methotrexate